Skip to main content

Peer Review reports

From: Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China

Original Submission
28 Jun 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 Aug 2021 Reviewed Reviewer Report
15 Aug 2021 Reviewed Reviewer Report
31 Aug 2021 Author responded Author comments - Xinping Sha
Resubmission - Version 3
31 Aug 2021 Submitted Manuscript version 3
5 Sep 2021 Reviewed Reviewer Report
17 Sep 2021 Reviewed Reviewer Report
22 Sep 2021 Author responded Author comments - Xinping Sha
Resubmission - Version 4
22 Sep 2021 Submitted Manuscript version 4
23 Sep 2021 Author responded Author comments - Xinping Sha
Resubmission - Version 5
23 Sep 2021 Submitted Manuscript version 5
28 Sep 2021 Author responded Author comments - Xinping Sha
Resubmission - Version 6
28 Sep 2021 Submitted Manuscript version 6
12 Oct 2021 Author responded Author comments - Xinping Sha
Resubmission - Version 7
12 Oct 2021 Submitted Manuscript version 7
21 Oct 2021 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
22 Oct 2021 Editorially accepted
6 Nov 2021 Article published 10.1186/s12913-021-07211-8

You can find further information about peer review here.

Back to article page